The bacterial envelope as a target for novel anti-MRSA antibiotics.
about
Antimicrobial Peptides Targeting Gram-Positive BacteriaIdentification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening StrategyInsights into the Mechanism of Action of Bactericidal LipophosphonoxinsDe novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications.Challenges of antibacterial discoveryLytic transglycosylase MltB of Escherichia coli and its role in recycling of peptidoglycan strands of bacterial cell wallA miniature mimic of host defense peptides with systemic antibacterial efficacy.Vancomycin analogs: Seeking improved binding of d-Ala-d-Ala and d-Ala-d-Lac peptides by side-chain and backbone modifications.Lipid-II forms potential "landing terrain" for lantibiotics in simulated bacterial membrane.Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin.Anti-inflammatory, antioxidant, and antimicrobial activities of Cocos nucifera var. typica.Genetics of antimicrobial resistance in Staphylococcus aureus.Antibacterial and synergic effects of gallic acid-grafted-chitosan with β-lactams against methicillin-resistant Staphylococcus aureus (MRSA).The biofilm inhibitor carolacton disturbs membrane integrity and cell division of Streptococcus mutans through the serine/threonine protein kinase PknB.Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles.Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the hypervirulent Pseudomonas aeruginosa strain LESB58.Total synthesis of N-acetylglucosamine-1,6-anhydro-N-acetylmuramylpentapeptide and evaluation of its turnover by AmpD from Escherichia coliAnti-methicillin Resistant Staphylococcus aureus Compound Isolation from Halophilic Bacillus amyloliquefaciens MHB1 and Determination of Its Mode of Action Using Electron Microscope and Flow Cytometry Analysis.Ultrastructural changes in methicillin-resistant Staphylococcus aureus induced by positively charged silver nanoparticlesTargeting bacterial membrane function: an underexploited mechanism for treating persistent infectionsThe membrane as a target for controlling hypervirulent Clostridium difficile infections.Potential Antibacterial Targets in Bacterial Central Metabolism.De novo designed synthetic mimics of antimicrobial peptides.Synthetic mimics of antimicrobial peptides--a versatile ring-opening metathesis polymerization based platform for the synthesis of selective antibacterial and cell-penetrating polymers.Membrane Disruption and Enhanced Inhibition of Cell-Wall Biosynthesis: A Synergistic Approach to Tackle Vancomycin-Resistant Bacteria.Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.Membrane-directed high bactericidal activity of (gold nanoparticle)-polythiophene composite for niche applications against pathogenic bacteria.A Vancomycin Derivative with a Pyrophosphate-Binding Group: A Strategy to Combat Vancomycin-Resistant Bacteria.Rapid Turbidimetric Assay to Determine the Potency of Daptomycin in Lyophilized Powder.Alteration of Zeta potential and membrane permeability in bacteria: a study with cationic agents.Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections.Enzymatic investigation of the Staphylococcus aureus type I signal peptidase SpsB - implications for the search for novel antibiotics.Chlorinated emodin as a natural antibacterial agent against drug-resistant bacteria through dual influence on bacterial cell membranes and DNA.A prospective antibacterial for drug-resistant pathogens: a dual warhead amphiphile designed to track interactions and kill pathogenic bacteria by membrane damage and cellular DNA cleavage.Mechanism of Azalomycin F5a against Methicillin-Resistant Staphylococcus aureus.Analysis of antibiotics resistant genes in different strains of Staphylococcus aureus.Development of biomaterial surfaces with and without microbial nanosegmentsCharacterization of the antibiotic compound no. 70 produced by Streptomyces sp. IMV-70
P2860
Q28077888-3544F20A-DE46-4C0F-845E-EE621604627AQ28547787-595C57AF-0797-46BB-B10E-EE340F9715C4Q28551859-7E2DCDB1-EC15-4E17-8D5D-6D2D1FA68FB5Q33598664-654C2064-BB19-428F-9176-3795F5D03A56Q33793074-86A7D73A-7F9F-42B0-BCEA-B6A3D11A6415Q33821551-04DC8F56-B9E2-401A-B73A-25B6CD124E0EQ33868731-1FFDFF5F-63A8-49E8-8D2C-8F09B5886465Q33944429-642FF89C-F21B-4384-8215-A56FD13EF93DQ34339406-3BF76264-2E81-4663-A612-5FE55581B211Q34448260-E1779F7F-F53B-4535-BA03-070BF479D0F9Q34726320-B257547F-9552-4821-BB9F-EBFF063809C6Q34984662-88B8753D-F46C-43B1-A109-EEC52395C6E5Q35250471-FB1FAAA6-DE11-4062-91D4-29DA1D17008CQ35272640-BE43FBFE-F3C9-4251-B95F-BE9CBE93960CQ35689986-2D1F1411-2004-421F-BD94-8015239CA192Q35746038-4080812A-8D68-4810-83BB-84F4516E1C79Q35777977-0DE1709A-30F6-4438-B14F-0FFA504D1CC3Q36115535-D412484C-8F9F-4611-84D9-30EE69434703Q36389808-61831D59-815C-43C0-A53C-0DCC248F58FBQ36393640-E608EE6B-1F91-46E1-8086-CA7BB17DC2E9Q36963920-9A0AF8F3-8E4E-40C6-AF65-C10DBFE89C59Q37239919-B2EC5978-FE13-48F3-95E6-B8E5AF03DC2FQ37321460-CCF6A527-1235-4EF9-B627-874008A48DC5Q37607151-C313F89D-3B63-4B65-9359-ACAFA41E3168Q38952894-575BAACF-EFAB-4DDF-A21C-4A029E938AB5Q39352419-2EC51C13-FF29-405C-BE72-8A8B1D454BAEQ39513743-457BE188-6FC9-43E3-B5EF-3CF0FB5AFFE8Q40742571-281E931F-A140-463A-B5FB-0608CCD0EB20Q41610683-37447FA6-96F9-49F3-A3E4-091B5D125C70Q41979547-5DDC3192-58A6-4FE2-9D88-F18027D36351Q41981409-E12D8BDA-A91D-46C6-861C-E0E044E0CE5BQ42170829-F2CDC7FE-1495-47FA-B8EA-C6B25BD5D297Q42371038-C83181A1-1F2C-4A21-A052-0BF5DBCB3DADQ53046888-BCBF2DDE-FF01-44D6-BE6A-B205AA4FD912Q54981445-9189B906-8EE9-44B4-8DAE-A1B9CD40571CQ55002498-54DD345B-9021-410D-9117-E56F525474FFQ57083404-0BE06C58-F021-4AFD-BBA2-3F28BA0E2AD7Q58914859-5953872D-B993-4D8E-B05E-1EF5CA046514
P2860
The bacterial envelope as a target for novel anti-MRSA antibiotics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The bacterial envelope as a target for novel anti-MRSA antibiotics.
@en
The bacterial envelope as a target for novel anti-MRSA antibiotics.
@nl
type
label
The bacterial envelope as a target for novel anti-MRSA antibiotics.
@en
The bacterial envelope as a target for novel anti-MRSA antibiotics.
@nl
prefLabel
The bacterial envelope as a target for novel anti-MRSA antibiotics.
@en
The bacterial envelope as a target for novel anti-MRSA antibiotics.
@nl
P2093
P1476
The bacterial envelope as a target for novel anti-MRSA antibiotics.
@en
P2093
Françoise Van Bambeke
Marc J Struelens
Marie-Paule Mingeot-Leclercq
Paul M Tulkens
P304
P356
10.1016/J.TIPS.2007.12.004
P577
2008-02-11T00:00:00Z